{
    "Trade/Device Name(s)": [
        "VITROS XT Chemistry Products ALB-TP Slides"
    ],
    "Submitter Information": "Ortho-Clinical Diagnostics, Inc.",
    "510(k) Number": "K191316",
    "Predicate Device Reference 510(k) Number(s)": [
        "K023875"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CIX"
    ],
    "Summary Letter Date": "June 7, 2019",
    "Summary Letter Received Date": "May 15, 2019",
    "Submission Date": "May 14, 2019",
    "Regulation Number(s)": [
        "21 CFR 862.1035"
    ],
    "Regulation Name(s)": [
        "Albumin test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Albumin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Glass red top tube",
        "Plastic red top tube",
        "Serum Separator Tube (SST)",
        "Sodium Heparin tube",
        "Lithium Heparin tube",
        "Plasma Separator Tube (PST)"
    ],
    "Instrument(s)/Platform(s)": [
        "VITROS XT 7600 Integrated System"
    ],
    "Method(s)/Technology(ies)": [
        "Colorimetric",
        "Reflectance spectrophotometry",
        "Bromcresol green (BCG) dye binding"
    ],
    "Methodologies": [
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Slide"
    ],
    "Document Summary": "FDA 510(k) summary for VITROS XT Chemistry Products ALB-TP Slides for quantitative measurement of albumin in serum and plasma using the VITROS XT 7600 Integrated System.",
    "Indications for Use Summary": "Quantitatively measures albumin concentration in serum and plasma for the diagnosis and treatment of diseases involving primarily the liver or kidneys using the VITROS XT 7600 Integrated System.",
    "fda_folder": "Clinical Chemistry"
}